Radiation therapy oncology group 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer

Stuart J. Wong, Kathryn Winter, Neal J. Meropol, Pramila Rani Anne, Lisa Kachnic, Asif Rashid, James C. Watson, Edith Mitchell, Jondavid Pollock, Robert Jeffrey Lee, Michael Haddock, Beth A. Erickson, Christopher G. Willett

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Radiation therapy oncology group 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy